1 Bariatic
1 Bariatic
1 Bariatic
2
What is Morbid Obesity?
Chronic multi-factorial
metabolic disease
Life-long
Progressive
Degenerative
Life-threatening
Genetically related
http://win.niddk.nih.gov/statistics/index.htm
13
Morbid Obesity is
a Metabolic
Disease
As BMI increases, adipose tissue becomes metabolically active
and
Thesesecretes hormones
hormones influence insulin resistance, hyperlipidemia,
inflammation, thrombosis, and hypertension
14
The Disease of Morbid Obesity
Neuropeptides and neurotransmitters in the brain, mainly the hypothalamus, and
other hormones affect satiety, appetite and weight regulation
15
Obesity and Neurohormonal
Influences
Located in the brain
Uncoupling
Reduced hepatic glucose proteins 2 and 3
17
Pathogenesis of Obesity
Behavior and lifestyle habits are often
determinants in the development of the
disease
20
Test Your
Knowledge
Ghrelin is a hormone which is secreted by
adipose tissue and decreases hunger
True
False
21
Co-Morbidities of Obesity
Co-morbidities are conditions or diseases
caused by or made worse by obesity
Hyperinsulinemia
Hyperglycemia
Hypertension
Heart Disease
25
American Heart Association
Definition of Metabolic
Syndrome
Increased waist circumference: > 40 inches for men or > 35
inches fortriglycerides:
Elevated women Equal or > 150 mg/dL
Considerations
Increased total blood volume
28
American Heart Association: http://www.americanheart.org/presenter.jhtml?identifier=1818
ECG Considerations
Increased fat deposits around the heart may lead to
degeneration of the conduction system which causes
lethal heart rhythms
Prolonged QT intervals
Non-specific flat/inverted T
waves in inferior leads
Pieracci, F.M., Barie, P.S., & Pomp, A. (2006). Critical Care of the Bariatric Patient. Critical Care Medicine, 34(6), 1796-1804.
Zacharias, A. Schwann. T. Riordan, C. et al (2005) Obesity and risk of new-onset of atrial fibrillation after cardiac surgery. Circulation 112 (32), 3247-3255
29
Diabetes Mellitus
Type 2 diabetes mellitus (DM) is strongly associated
with overweight and obesity in both genders and in all
ethnic groups
30
Renal Impact
Some drugs may impact the renal system
in high BMI patients due to high glomerular
filtration rates
If BMI is more than 30, nearly twice the risk for kidney failure
If BMI of 40 or above, seven times the risk of kidney failure
Blackwell Publishing Ltd. (2006, December 26). Obese Kidney Transplant Patients Twice As Likely To Die In The First Year Or Suffer Organ
Reference: June Journal of the American Society of Nephrology (2006) http://www.sciencedaily.com/releases/2006/01/060105082226.htm
31
Nonalcoholic Fatty Liver
If BMI > 40, the prevalence of:
Nonalcoholic fatty liver disease (NAFLD) is more than 95%
Nonalcoholic steatohepatitis (NASH) may be as high as
25%.
35
High Risk for Blood Clots
Obesity is characterized by:
Chronic inflammation
Decreased immunity
Hypercoagulability
• Decreased antithrombin-III
• Increased tumor necrosis factor α and interleukin-6
• Impaired neutrophil function
• Increased blood volume
36
Critical Care Medicine 2006 Jun;34(6):1796-804.
Prevent Blood Clots by Early
Ambulation
Mobilize patients early and frequently
The efficacy of sequential
compression devices and TED
hose for obese individuals is
unknown
Chronic inflammation and
hypercoagulation increase the clot
risk
There are limited studies about
anticoagulation and the obese
The weight of the large pannus
(abdominal fold) creates pressure
the riskdeep vessels and increases
on the
Critical Care Medicine 2006 Jun;34(6):1796-804.
37
Test Your
Knowledge
Which statement is not true about the increased risk for blood
clots and the obese individual?
Burns, S.M., Egloff, MB. Ryan, B. & Carpenter, R. (1994). Effect of Body Position on Respiratory Rate and Tidal
41
volume in Patients with Obesity, Abdominal Distention, and Acites. American Journal of Critical Care, (3), 102-106.
Pulmonary Considerations
Preoxygenate before procedures such as suctioning.It is vital.
43
OSA and
Obtain order Obesity
for Pulmonary Services if patient
uses CPAP at home
46
Weight and Drugs
Caution must be used for drugs highly soluble
in fat, especially with extended time duration,
> 12-24 hours include:
49
Venous Access
Landmark vessels may be hard to palpate or visualize.
Consider Infusion Services to avoid multiple IV
sticks. Midline and PICC catheters may be a
better option depending on the length of therapy.
50
GI Impact
Monitor for greater aspiration risk due to high:
gastric fluid volume
GI reflux
incidence of Hiatal Hernia
53
Test Your
Knowledge
Obesity is linked to certain types of
cancer
True
False
54
Treatment of
If BMI isObesity
25-26.9 with co-morbidities:
Advise patient of treatment options for diet, physical
activity, and behavioral change
59
What do you think?
60
Weight Bias in
Healthcare
A recent study reported that only 2% of the
dietitian students had a neutral or positive attitude
about obese persons
61
Physicians and Weight Bias
In several anonymous self report surveys, they view obese
patients as:
“Noncompliant, lazy, lacking self control,
unsuccessful, unintelligent, and dishonest”
Overall, physicians:
spent less time with patients
assigned more negative symptoms
had reluctance to perform certain screenings
Reference: Rebecca M. Puhl, PhD and Kelly D. Brownell, PhD and the Obesity Society
62
Impact on Patient Care
Patients may delay seeking or cancel
preventative health services and exams
63
Providing Weight Sensitive
Care
Ask permission from the patient when
you: discuss their weight or BMI
weigh them
64
Providing Weight Sensitive
Care
Avoid demeaning phrases such as “fluffy”, “fat”,
etc
65
Patient Education
If a patient is interested in weight loss options
at Sharp, the patient may attend an out-
patient class. These are two options:
False
67
Claims of Negligence
Failure to:
70
Claims of Negligence
Failure to:
71
How are we providing the
best care
at Sharp Healthcare?
72
System Task Force
Safe Care of the Bariatric Patient
Recommended and supported by CNOs and System
Safety Steering Committee based on identified risks
of this patient population
Comprised of representatives across the system:
SMH
Cheryl Holsworth RN, Senior Specialist, Bariatric Surgery
Michael Drafz RN, Lead, Vascular Access Services
Judd Feiler, Lead, Physical Therapy
SGH
Bethanie Martin RN, Lead 5 East
Ron Owen, Manager, Pulmonary Services
SCOR
Bryn Hogan RN, Lead ACC
MBHWN
Ellen Fleischman RN, RD, Manager MIS
Bernadette Bongato RN, Nursing Specialist OR
SCVMC
Deanna White RN, Manager, Acute Care
Marquet Johnson RN, CNS, PCU
System Representatives
Albert Rizos, PharmD, System Senior Clinical Pharmacy Specialist
Cheryl Dailey RN, Director, Patient Safety
Francine Parent RN, Senior Specialist, System Supply Chain Services
73
Focus Areas of Bariatric Task
Force
Ensure that our clinical staff have ready access to
supplies, products and equipment which are weight
and size appropriate
Resource Experts
Thomas Hayes
Administrative Coordinator Bariatric Program
76
Phone 858-939-3010, [email protected]
Conclusions about Morbid Obesity
It is a metabolic disease
Special thanks to the following SHC specialists for their valuable input:
82